Sun Pharmaceutical Industries (₹639.6) is ruling at a crucial level. The stock finds support at ₹610 and the crucial one at ₹572. A close below the latter will confirm the bearish trend. Only a close above ₹724 will change the outlook positive. We expect the stock to move in the band between ₹610 and ₹720 in the medium term.
F&O pointers: The Sun Pharma futures witnessed a steady build up in open interest positions, despite the fall in underlying price. Option trading suggests limited downside, as ₹640-strike and ₹660-strike put options added open positions. Sun Pharma may face resistance at ₹700, where call options added more open positions.
Strategy: We suggest a calendar bull-call spread strategy for traders. This can be initiated by selling ₹640-call of April strike and simultaneously buying the same call option in May series.
While ₹640-strike April call closed at ₹8.25, the same strike in May closed at ₹23.05. With market lot being 700 shares, one has to shell out ₹10,360 to initiate the strategy. The maximum loss would be the premium paid, for which Sun Pharma has to close at or below at ₹640 at the time of May contract expiry. However, profit can be unlimited if Sun Pharma rallies in May. A close above ₹655 will start yielding profits.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.